Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

References for PMC Articles for PubMed (Select 17967185)

1.

Multiparameter calibration of a natural history model of cervical cancer.

Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ.

Am J Epidemiol. 2007 Jul 15;166(2):137-50. Epub 2007 May 25.

2.

Model for assessing human papillomavirus vaccination strategies.

Elbasha EH, Dasbach EJ, Insinga RP.

Emerg Infect Dis. 2007 Jan;13(1):28-41.

3.

Prevalence of HPV infection among females in the United States.

Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE.

JAMA. 2007 Feb 28;297(8):813-9.

PMID:
17327523
4.

Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty.

Van de Velde N, Brisson M, Boily MC.

Am J Epidemiol. 2007 Apr 1;165(7):762-75. Epub 2007 Feb 1.

5.

Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.

Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):360-70. Erratum in: Obstet Gynecol. 2007 Apr;109(4):1002.

PMID:
17267837
6.

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.

French KM, Barnabas RV, Lehtinen M, Kontula O, Pukkala E, Dillner J, Garnett GP.

Br J Cancer. 2007 Feb 12;96(3):514-8. Epub 2007 Jan 23.

7.

The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm.

Campbell H, Briggs A, Buxton M, Kim L, Thompson S.

J Health Serv Res Policy. 2007 Jan;12(1):11-7. Review.

PMID:
17244392
8.
9.

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E.

Gynecol Oncol. 2007 Jan;104(1):232-46. Epub 2006 Nov 3. Review.

PMID:
17084886
10.

Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems.

Rodriguez-Fernandez M, Egea JA, Banga JR.

BMC Bioinformatics. 2006 Nov 2;7:483.

11.
12.

The Wisconsin Breast Cancer Epidemiology Simulation Model.

Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL.

J Natl Cancer Inst Monogr. 2006;(36):37-47.

PMID:
17032893
13.

Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

Berry DA, Inoue L, Shen Y, Venier J, Cohen D, Bondy M, Theriault R, Munsell MF.

J Natl Cancer Inst Monogr. 2006;(36):30-6.

PMID:
17032892
14.

Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.

Shechter SM, Schaefer AJ, Braithwaite RS, Roberts MS.

Med Decis Making. 2006 Sep-Oct;26(5):550-3.

PMID:
16997930
15.

Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.

McMahon PM, Zaslavsky AM, Weinstein MC, Kuntz KM, Weeks JC, Gazelle GS.

Med Decis Making. 2006 Sep-Oct;26(5):497-511.

PMID:
16997927
16.
17.

Chapter 7: Achievements and limitations of cervical cytology screening.

Kitchener HC, Castle PE, Cox JT.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/63-70. Review.

PMID:
16950019
18.

Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.

Goldie SJ, Goldhaber-Fiebert JD, Garnett GP.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/155-63. Review.

PMID:
16950003
19.

Chapter 13: Current findings from prophylactic HPV vaccine trials.

Koutsky LA, Harper DM.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/114-21. Epub 2006 Jun 23. Review.

PMID:
16949998
20.

Chapter 2: The burden of HPV-related cancers.

Parkin DM, Bray F.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25. Review.

PMID:
16949997
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk